Aktuell 13 Mayo 2024 Kanton Zug fördert Institut für Blockchain-Forschung Der Kanton Zug beteiligt sich an den Aufbaukosten eines Instituts für Blockchain-Forschung. Für das Projekt der Universität Luzern und der Hochsc...
News 13 Mayo 2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 10 Mayo 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 21 Nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 18 Oct 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Aktuell 21 Nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
Actualités 11 Oct 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
Press Release 15 Dic 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
News 26 Ene 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
News 13 Sep 2023 HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award Western Switzerland’s burgeoning start-up scene witnessed another remarkable year of innovation and growth as Haya Therapeutics won the first pla...
News 11 Ene 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News 29 Sep 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Member of the Month 03 Feb 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...